CTTN and breast cancer: Elevated cortactin expression has been linked to tumorigenesis, and has been shown to correlate with poor clinical outcome in breast cancer [11], head and neck squamous cell carcinoma [12], hepatocellular carcinoma [13], colorectal adenocarcinoma [14], and melanoma [15].